Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
4/10/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Dear Colleague Letter ,
Department of Health and Human Services (HHS) ,
Federal Budget ,
Final Rules ,
Health Care Providers ,
Inpatient Prospective Payment System (IPPS) ,
MACPAC ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
MedPAC ,
OMB ,
Political Candidates ,
Prescription Drugs ,
Privacy Laws ,
Telehealth ,
Value-Based Care
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
3/25/2024
/ Appropriations Bill ,
CBO Report ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
MACPAC ,
Medicaid ,
Medicare ,
MedPAC ,
Proposed Legislation ,
Public Health ,
Regulatory Agenda ,
Secretary of HHS
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more
3/7/2024
/ Appropriations Bill ,
Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Federal Funding ,
Federal Trade Commission (FTC) ,
Final Rules ,
Health Care Providers ,
Health Insurance ,
Legislative Agendas ,
Medicaid ,
Medicare Advantage ,
Medicare Part D ,
MedPAC ,
MIPS ,
National Institute of Health (NIH) ,
OMB ,
Pediatrics ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drug Coverage ,
Prescription Drugs ,
Private Equity ,
Proposed Legislation ,
Public Comment ,
Public Health ,
Reproductive Healthcare Issues ,
Request For Information ,
Working Groups
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/28/2024
/ Affordable Care Act ,
Appropriations Bill ,
Artificial Intelligence ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Dear Colleague Letter ,
Diversity ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Information Reports ,
Medical Research ,
National Institute of Health (NIH) ,
PHI ,
Political Parties ,
Prescription Drugs ,
Research and Development ,
Webinars
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
2/7/2024
/ American Medical Association ,
Biden Administration ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Hospitals ,
Legislative Agendas ,
Medicare ,
Physicians ,
Prescription Drugs ,
Proposed Legislation ,
Public Meetings
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more
1/24/2024
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Chevron Deference ,
Congressional Committees ,
Continuing Resolution ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Dispute Resolution ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medical Research ,
Medicare ,
Mental Health ,
Prescription Drugs ,
World Health Organization